Cargando…
The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF-1 Transcriptional Activity in Glioblastoma Multiforme
Glioblastoma multiforme (GBM) accounts for about 38% of primary brain tumors in the United States. GBM is characterized by extensive angiogenesis induced by vascular growth factors and cytokines. The transcription of these growth factors and cytokines is regulated by the Hypoxia-Inducible-Factor-1(H...
Autores principales: | Wang, Enfeng, Zhang, Chunyang, Polavaram, Navatha, Liu, Fengming, Wu, Gang, Schroeder, Mark A., Lau, Julie S., Mukhopadhyay, Debabrata, Jiang, Shi-Wen, O'Neill, Brian Patrick, Datta, Kaustubh, Li, Jinping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900478/ https://www.ncbi.nlm.nih.gov/pubmed/24465898 http://dx.doi.org/10.1371/journal.pone.0086102 |
Ejemplares similares
-
Factor-inhibiting HIF (FIH) promotes lung cancer progression
por: García-del Río, Ana, et al.
Publicado: (2023) -
Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis
por: Khan, M N, et al.
Publicado: (2011) -
The conservation and functionality of the oxygen-sensing enzyme Factor Inhibiting HIF (FIH) in non-vertebrates
por: Hampton-Smith, Rachel J., et al.
Publicado: (2019) -
Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1α stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment
por: Feng, Jianbo, et al.
Publicado: (2018) -
Regulation of Transactivation at C-TAD Domain of HIF-1α by Factor-Inhibiting HIF-1α (FIH-1): A Potential Target for Therapeutic Intervention in Cancer
por: Rani, Soniya, et al.
Publicado: (2022)